World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
44
Citations
6427
World Ranking
4804
National Ranking
2155

Raymond P. Goodrich publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Raymond P. Goodrich sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 130 publications — 10th percentile

10% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Raymond P. Goodrich D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Raymond P. Goodrich sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 44 D-Index — 4th percentile

4% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Raymond P. Goodrich is affiliated with Colorado State University in the United States and has contributed extensively to the field of Medicine, particularly focusing on Infectious Diseases, Epidemiology, Genetics, Immunology, and Biotechnology.

The scientist's main research topics include:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Virus-based gene therapy research
  • Immunotherapy and Immune Responses
  • SARS-CoV-2 detection and testing
  • Viral Infections and Outbreaks Research
  • Hepatitis B Virus Studies

Frequent publication venues where Raymond P. Goodrich's work appears include:

  • Transfusion
  • bioRxiv (Cold Spring Harbor Laboratory)
  • PLoS ONE
  • Vox Sanguinis
  • Pathogens

Notable recent papers authored or co-authored by Raymond P. Goodrich are:

  • "Pathogen reduction of SARS-CoV-2 virus in plasma and whole blood using riboflavin and UV light" (2020, PLoS ONE)
  • "Pathogen Reduction of SARS-CoV-2 Virus in Plasma and Whole Blood using Riboflavin and UV Light" (2020, bioRxiv (Cold Spring Harbor Laboratory))
  • "A Whole Virion Vaccine for COVID-19 Produced via a Novel Inactivation Method and Preliminary Demonstration of Efficacy in an Animal Challenge Model" (2021, Vaccines)
  • "SARS-CoV-2 seroprevalence among blood donors in Uganda: 2019-2022" (2023, Transfusion)
  • "The Mirasol Evaluation of Reduction in Infections Trial (MERIT): study protocol for a randomized controlled clinical trial" (2022, Trials)

Raymond P. Goodrich collaborates regularly with several frequent co-authors, including:

  • Lindsay Hartson
  • Izabela Ragan
  • Taru S. Dutt
  • Marcela Henao-Tamayo
  • Evan M. Bloch

Best Publications

  • Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light

    Patrick H. Ruane;Richard Edrich;Deanna Gampp;Shawn D. Keil

  • Riboflavin and UV-light based pathogen reduction: extent and consequence of DNA damage at the molecular level.

    Vijay Kumar;Owen Lockerbie;Shawn D. Keil;Patrick H. Ruane

  • Pathogen Reduction Technology Treatment of Platelets, Plasma and Whole Blood Using Riboflavin and UV Light.

    Susanne Marschner;Raymond Goodrich

  • Primary hemostatic capacity of whole blood: a comprehensive analysis of pathogen reduction and refrigeration effects over time

    Heather F. Pidcoke;Steve J. McFaul;Steve J. McFaul;Anand K. Ramasubramanian;Anand K. Ramasubramanian;Bijaya K. Parida;Bijaya K. Parida

  • The Mirasol PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trends.

    Raymond P. Goodrich;Richard A. Edrich;Junzhi Li;Jerard Seghatchian

  • Method of inactivation of viral and bacterial blood contaminants

    Matthew S. Platz;Raymond P. Goodrich;Nagendar Yerram

  • The use of riboflavin for the inactivation of pathogens in blood products.

    Goodrich Rp

  • Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reduction.

    James P. AuBuchon;Louise Herschel;Jill Roger;Harry Taylor

  • A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology

    J‐P. Cazenave;G. Folléa;L. Bardiaux;J.‐M. Boiron

  • Effect of Plasmodium inactivation in whole blood on the incidence of blood transfusion-transmitted malaria in endemic regions: the African Investigation of the Mirasol System (AIMS) randomised controlled trial

    Jean-Pierre Allain;Alex K Owusu-Ofori;Sonny Michael Assennato;Susanne Marschner

  • Toxicity testing of a novel riboflavin-based technology for pathogen reduction and white blood cell inactivation.

    Heather L. Reddy;Anthony D. Dayan;Joy Cavagnaro;Shayne Gad

  • Pathogen inactivation of Leishmania donovani infantum in plasma and platelet concentrates using riboflavin and ultraviolet light

    L. J. Cardo;F. J. Rentas;L. Ketchum;J. Salata

  • Correlation of in vitro platelet quality measurements with in vivo platelet viability in human subjects.

    Raymond P. Goodrich;Junzhi Li;Henry Pieters;Robert Crookes

  • METODO PARA SEPARAR PARTICULAS.

    Green Todd Curtis;Goodrich Raymond P

  • Method and apparatus for inactivation of biological contaminants using photosensitizers

    Larry Joe Dumont;Raymond Paul Goodrich

  • White blood cell inactivation after treatment with riboflavin and ultraviolet light

    Susanne Marschner;Loren D. Fast;William M. Baldwin;Sherrill J. Slichter

  • Pathogen reduction of SARS-CoV-2 virus in plasma and whole blood using riboflavin and UV light.

    Izabela Ragan;Lindsay Hartson;Heather Pidcoke;Richard Bowen

  • Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates.

    S. Perez‐Pujol;R. Tonda;M. Lozano;B. Fuste

  • Method of freezing cells and cell-like materials

    Raymond P Goodrich;Samuel O S Coker;Franciose G Arnaud;Roger W Hackett

  • Preservation of metabolic activity in lyophilized human erythrocytes.

    Raymond P. Goodrich;Samuel O. Sowemimo-Coker;Charles R. Zerez;Kouichi R. Tanaka

  • Pathogen inactivation of Trypanosoma cruzi in plasma and platelet concentrates using riboflavin and ultraviolet light

    Lisa J. Cardo;Jeanne Salata;Juan Mendez;Heather Reddy

  • A laboratory comparison of pathogen reduction technology treatment and culture of platelet products for addressing bacterial contamination concerns.

    Raymond P. Goodrich;Denise Gilmour;Nick Hovenga;Shawn D. Keil

  • Functional inactivation of white blood cells by Mirasol treatment.

    Loren D. Fast;Gilbert DiLeone;Junzhi Li;Raymond Goodrich

  • Design and development of a method for the reduction of infectious pathogen load and inactivation of white blood cells in whole blood products.

    Raymond P. Goodrich;Suzann Doane;Heather L. Reddy

Frequent Co-Authors

Matthew S. Platz
Matthew S. Platz University of Hawaii at Hilo
Philip J. Norris
Philip J. Norris University of California, San Francisco
Marcus O. Muench
Marcus O. Muench University of California, San Francisco
Dana V. Devine
Dana V. Devine University of British Columbia
Jean-Pierre Allain
Jean-Pierre Allain University of Cambridge
Richard A. Bowen
Richard A. Bowen Colorado State University
Gines Escolar
Gines Escolar University of Barcelona
William M. Baldwin
William M. Baldwin Cleveland Clinic Lerner College of Medicine
Jose A. Cancelas
Jose A. Cancelas Cincinnati Children's Hospital Medical Center
Michael P. Busch
Michael P. Busch University of California, San Francisco

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, there are various related online degrees and career pathways in healthcare that can complement your expertise. Nursing is a popular choice, with several programs designed for different entry levels and backgrounds.

If you don’t have a nursing background but want to enter the field, the best online RN programs for non nurses offer flexible options to help you transition smoothly into registered nursing.

For quicker entry into nursing, many students look for easiest ABSN programs to get into. These accelerated Bachelor of Science in Nursing programs are ideal for those who already hold a degree and want to fast-track their nursing education.

Similarly, those seeking foundational nursing roles might consider which LPN programs are easiest to get into. Licensed Practical Nurse programs provide a solid stepping stone into patient care and medical environments.

For advanced practice opportunities, explore easy nurse practitioner programs to get into. These programs prepare you for specialized roles that align well with immunology, like infectious disease or immunotherapy-related care.

Choosing the right online program tailored to your current qualifications can greatly enhance your career in immunology and healthcare.

Best Scientists Citing Raymond P. Goodrich

Trending Scientists

Recently Published Articles